News | March 20, 2026
Glenmark Therapeutics USA launches fluticasone propionate nasal spray
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
Subscribe To Our Newsletter & Stay Updated
